The store will not work correctly when cookies are disabled.
4-[6-Amino-5-(benzyloxy)pyridin-3-yl]benzoic acid
ID: ALA4756492
PubChem CID: 21111459
Max Phase: Preclinical
Molecular Formula: C19H16N2O3
Molecular Weight: 320.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ncc(-c2ccc(C(=O)O)cc2)cc1OCc1ccccc1
Standard InChI: InChI=1S/C19H16N2O3/c20-18-17(24-12-13-4-2-1-3-5-13)10-16(11-21-18)14-6-8-15(9-7-14)19(22)23/h1-11H,12H2,(H2,20,21)(H,22,23)
Standard InChI Key: QPPKQHCOWKQUMH-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
29.6362 -17.4664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6351 -18.2859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3431 -18.6949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0528 -18.2855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0499 -17.4628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3413 -17.0575 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.7576 -18.6922 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.7561 -17.0515 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9289 -18.6942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2213 -18.2834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5137 -18.6907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5126 -19.5088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2250 -19.9178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9296 -19.5081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8021 -19.9194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0941 -19.5111 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.8025 -20.7365 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.7578 -19.5094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4656 -19.9178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4622 -20.7321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1692 -21.1405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8778 -20.7317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8750 -19.9103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1674 -19.5056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
5 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
2 9 1 0
15 16 1 0
15 17 2 0
12 15 1 0
7 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 320.35 | Molecular Weight (Monoisotopic): 320.1161 | AlogP: 3.61 | #Rotatable Bonds: 5 |
Polar Surface Area: 85.44 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.01 | CX Basic pKa: 7.04 | CX LogP: 1.69 | CX LogD: 1.19 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.75 | Np Likeness Score: -0.35 |
References
1. Dow RL,Ammirati M,Bagley SW,Bhattacharya SK,Buckbinder L,Cortes C,El-Kattan AF,Ford K,Freeman GB,Guimarães CRW,Liu S,Niosi M,Skoura A,Tess D. (2018) 2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety., 61 (7): [PMID:29570292] [10.1021/acs.jmedchem.8b00152] |